XBOT Overview

Acquisition Announcement: RealBotix Corp has announced its intention to acquire 100% of RealBotix, LLC in an all-stock deal.

Strategic Move: This acquisition is part of a strategic effort to consolidate resources and enhance the company's market position in the robotics and AI sector.

Deal Closure: The deal involving Realbotix has closed, leading to significant changes in ownership.

Ownership Dilution: The parent company will own between 75% and 90% of fully diluted common shares of the combined company.

Acquisition Announcement: Onconetix Inc. will acquire 100% of the issued and outstanding equity interests of Real Botix in an all-stock transaction.

Strategic Move: This acquisition aims to enhance Onconetix's portfolio and market position within the biotechnology sector.

Private Placement Announcement: Realbotix Corp. has successfully closed a brokered private placement of 14 million units at C$0.50 each, raising a total of C$7 million, with plans to use the funds for advancing AI-powered humanoid robots and general corporate purposes.

Details of the Offering: Each unit consists of one common share and one warrant, allowing the purchase of additional shares at C$0.75 until October 24, 2030. The offering was conducted under specific Canadian securities regulations and is not available for sale in the United States.

Company's Growth Strategy: CEO Andrew Kiguel expressed confidence that the new capital will enable Realbotix to accelerate growth in its products and services, enhancing its financial position for future investments.

Forward-Looking Statements: The announcement includes forward-looking statements regarding the use of proceeds and future expectations, which are subject to risks and uncertainties that may affect actual outcomes.

Private Placement Announcement: Realbotix Corp. has increased its brokered private placement to issue up to 14 million units at C$0.50 each, aiming for gross proceeds of up to C$7 million, primarily driven by strong investor demand.

Use of Proceeds: The funds raised will be utilized for advancing the engineering, design, and commercialization of AI-powered humanoid robots, along with general corporate purposes.

Regulatory Compliance: The offering is subject to regulatory approvals and will be available to investors in Canada (excluding Quebec) and potentially in the U.S. under certain exemptions.

Forward-Looking Statements: The announcement includes forward-looking statements regarding the completion of the offering and expected timelines, which are subject to various risks and uncertainties.

Launch of Realbotix Robotic AI Vision System: Realbotix Corp. has introduced its new AI Vision System for humanoid robots, enhancing their ability to recognize and interact with humans and objects in real-time, thereby improving user engagement and situational awareness.

Applications Across Industries: The system's capabilities are set to transform various sectors including healthcare, retail, smart homes, and entertainment by enabling personalized interactions, monitoring, and adaptive responses, while also featuring advanced realistic eyeball technology for enhanced visual realism.